E. Werle
Impact in
- Genetics top 1%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Biotechnology top 2%
- Enzyme Production and Characterization
Papers in
-
- Polyamine Metabolism and Applications 24
- Protein Hydrolysis and Bioactive Peptides 13
- Enzyme function and inhibition 13
- Chemical Synthesis and Analysis 12
- Genetics 36
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 35
- Co-authors
- I. Trautschold (19 shared papers)Hans Fritz (34 shared papers)W. Lorenz (23 shared papers)Karl HOCHSTRASSER (19 shared papers)R Vogel (2 shared papers)F. Fiedler (11 shared papers)Rudolf Amann (4 shared papers)H. Schievelbein (13 shared papers)
In The Last Decade
E. Werle
208 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 128
- Genetics 612
- Biotechnology 263
- Biochemistry 173
- Molecular Biology 1.4k
- Hematology 203
Countries citing papers authored by E. Werle
This map shows the geographic impact of E. Werle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Werle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Werle more than expected).
Fields of papers citing papers by E. Werle
This network shows the impact of papers produced by E. Werle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Werle. The network helps show where E. Werle may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Werle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Natural proteinase inhibitors | 1968 | 147 |
| 2 | 1972 | 87 | |
| 3 | 1967 | 74 | |
| 4 | Das Kallikrein-Kinin-System und Seine Inhibitororen | 1968 | 73 |
| 5 | 1970 | 60 | |
| 6 | 1966 | 54 | |
| 7 | 1966 | 50 | |
| 8 | 1967 | 46 | |
| 9 | [Isolation and characterisation of a protease inhibitor from human bronchial secretion]. | 1972 | 45 |
| 10 | 1971 | 45 | |
| 11 | 1956 | 44 | |
| 12 | 1991 | 42 | |
| 13 | 1969 | 42 | |
| 14 | 1957 | 39 | |
| 15 | 1952 | 38 | |
| 16 | 1969 | 37 | |
| 17 | 1952 | 35 | |
| 18 | 1967 | 34 | |
| 19 | 1969 | 33 | |
| 20 | 1969 | 33 |
About E. Werle
E. Werle is a scholar working on Molecular Biology, Genetics, Organic Chemistry, Biochemistry and Cell Biology, having authored 212 papers that have together received 2.9k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (35 papers), Polyamine Metabolism and Applications (24 papers), Amino Acid Enzymes and Metabolism (14 papers), Protein Hydrolysis and Bioactive Peptides (13 papers), Enzyme function and inhibition (13 papers), Chemical Synthesis and Analysis (12 papers), Enzyme Production and Characterization (11 papers) and Mast cells and histamine (11 papers). The work is most often cited by research in Genetics (612 citations), Biotechnology (263 citations), Biochemistry (173 citations), Molecular Biology (1.4k citations) and Hematology (203 citations). E. Werle has collaborated with scholars based in Germany, Austria and Latvia. Frequent co-authors include I. Trautschold, Hans Fritz, W. Lorenz, Karl HOCHSTRASSER, R Vogel, F. Fiedler, Rudolf Amann, H. Schievelbein, A. Schmal and A. Schauer. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Journal of Molecular Medicine, Die Naturwissenschaften, Annals of Hematology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.